S8820

Protease Inhibitor Cocktail

Name: Protease Inhibitor Cocktail
Brand: SIGMA

SIGMA FAST, tablet, for the inhibition of serine, cysteine, aspartic and metalloproteases, For General Use

Synonim(y):

inhibitor proteazy

Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych

About This Item

Kod UNSPSC:

12352200

NACRES:

NA.77

Kluczowe dokumenty

Wyświetl całą dokumentację

Pomoc techniczna

Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.

Pozwól nam pomóc

Pomoc techniczna

Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.

Pozwól nam pomóc

Product Name

SIGMAFAST^™ Protease Inhibitor Tablets, For General Use

pochodzenie biologiczne

bovine lung
bovine milk

Poziom jakości

200

Formularz

tablet

rozpuszczalność

water: 1 tablet/100mL, clear to hazy, colorless

temp. przechowywania

2-8°C

Opis ogólny

SIGMAFAST^™ Protease Inhibitor Tablets are a water-soluble tablet formulation containing a broad-spectrum cocktail of protease inhibitors, including AEBSF, E-64, bestatin, leupeptin, aprotinin, and EDTA. One tablet can make 100 mL of cocktail and can inhibit proteases present in up to 20 g of cell extract.

The use of SIGMAFAST Protease Inhibitor Tablets is not advised with HIS-Select^® products or other immobilized metal affinity chromatography (IMAC) products. These tablets contain EDTA, which is a metal chelator and can potentially remove metal ions from these affinity products.

Specyficzność

Inhibits serine, cysteine, aspartic, and metalloproteases.

Zastosowanie

SIGMAFAST Protease Inhibitor Tablets has been used:

to wash raw semen for membrane protein analysis
in a solution to incubate CD4+ T cells to obtain total cell lysates for western blot analyses
as a component of NP-40 buffer to homogenize the spinal cord tissue centered at the injury epicenter to conduct western blot analysis
as a component in radio-immunoprecipitation assay (RIPA) buffer to homogenize the spinal cord tissue centered at the injury center to detect neuregulin-1 beta 1 (Nrg-1ß1) in spinal cord tissue samples with enzyme-linked immunosorbent assay (ELISA)

These tablets have been optimized and tested for general use. They have been used in various applications, including collecting tracheae in combination with ice-cold radioimmunoprecipitation assay buffer to determine the tracheal basal cell fate, and homogenizing rat lung tissues for western blot analysis.

Cechy i korzyści

Broad-spectrum protease inhibition: inhibits serine, cysteine, aspartic, and metalloproteases, making it a versatile solution for protease inhibition in various applications.
Water-soluble tablet formulation: easy to use and prepare, with one tablet making 100 mL of cocktail.
Contains a cocktail of protease inhibitors: provides a comprehensive and effective solution for protease inhibition.
Tested and optimized for general use: proven performance and reliability for a wide range of applications.

Komponenty

AEBSF, 2 mM
Aprotinin, 0.3 μM
Bestatin, 130 μM
EDTA, 1 mM
E-64, 14 μM
Leupeptin, 1 μM

Ilość

One tablet makes 100 mL of cocktail. One mL is recommended for the inhibition of proteases equivalent to 1 mg of USP pancreatin. One tablet is recommended for the inhibition of proteases present in a maximum of 20 g of cell extract.

Postać fizyczna

Tablet that is water soluble.

Inne uwagi

For R&D use only. Not for drug, household, or other uses. Please consult the Safety Data Sheet for information regarding hazards and safe handling practices.